Katharina Ehrenhöfer-Wölfer

3PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 14, 2019
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.

Katharina Ehrenhöfer-Wölfer, Teresa Puchner, Cornelia Schwarz

|Jul 04, 2019
Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

William Farnaby, Manfred Koegl, Michael J Roy

|Jun 11, 2019
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

William Farnaby, Manfred Koegl, Michael J Roy

Pageof 1